6th Annual LifeSciences BC Access to Innovation


February 24, 2021


All Day


Event Links


Get Directions


Contact Info

"The life sciences sector is the best positioned to drive the economic recovery and competitiveness of British Columbia while developing innovative solutions, products and processes to address the complex issues facing the health system"

Life sciences is one of the fastest-growing sectors in the BC economy and as a sector is at the forefront of both developing innovations to address the COVID-19 pandemic and driving job creation and the economic recovery of the province.

2021 will mark the 6th Annual Access to Innovation Conference bringing together all stakeholders in the life sciences sector. The conference brings together leaders from across academia, research, health institutions, government, and industry. Broadly, the aim of the conference is to provide a venue for dialogue on topics of relevance to life sciences from scientific discovery, emerging trends, innovation, economic impact, translational science, and policies to advance the sector.

This year's conference will have sessions covering the following:

  • Importance of the life sciences ecosystem - economic contribution, opportunities to accelerate, importance of collaboration amongst all stakeholders
  • Pandemic preparedness
  • Scaling companies - how do we accelerate the growth of SMEs, spinning companies out of universities
  • Diversity & Inclusion
  • Adoption of virtual health - now and looking ahead
  • The optimization of patient treatments through the utilization of AI and quantum computing

Confirmed Moderators:

  • Ali Ardakani, Managing Director, Novateur Ventures
  • Dr. Federica Di Palma, Chief Scientific Officer & VP, Sectors, Genome BC
  • Nancy Harrison, Venture Partner, Amplitude Ventures
  • Dean Prelazzi, VP, Head of Business Development and Marketing, Fujitsu
  • Helen Sheridan, Chief Human Resources Officer, STEMCELL Technologies
  • Dr. Pascal Spothelfer, President and CEO, Genome BC

Confirmed Speakers:

  • Mary Ackenhusen, Senior Executive in Residence for Innovation, BC Ministry of Health
  • Alejandra Brown, President and Principal Consultant, Kirke Management Consulting
  • Professor Sir Mark Caulfield, Professor, Clinical Pharmacology & Chief Scientist, Genomics England
  • Kevin Chaplin, CEO, Kardium
  • Jennifer Cudlipp, Senior Vice President - BC and President, Excelleris Technologies, LifeLabs
  • Greg D'Avignon, President and CEO, Business Council of British Columbia
  • Pamela Fralick, President, Innovative Medicines Canada
  • Dr. Réka Gustafson, VP, Public Health and Wellness, PHSA & Deputy Provincial Health Officer, BC Centre for Disease Control
  • Dr. Jennifer Hamilton, Senior Director, New Ventures, Advisor, Impact Investing, Johnson & Johnson
  • Dr. Carl Hansen, CEO, AbCellera
  • David Helliwell, Co-founder and CEO, Thrive Health
  • Dr. Mojgan Hodaie, Professor, Department of Surgery, University of Toronto
  • Hon. John Horgan, Premier of British Columbia
  • Dr. Robert Huizinga, Executive Vice President of Research, Aurinia Pharma U.S., Inc.
  • Dr. Lana Janes, Venture Partner, adMare BioInnovations & Interim CEO, Abdera Therapeutics
  • Doug Janzen, Co-Founder, Managing Director, Northview Ventures & Chairman, CEO, Aequus Pharmaceuticals
  • Hon. Ravi Kahlon, Minister, Jobs, Economic Recovery and Innovation, Government of British Columbia
  • Nicholas Lee, Sr. Director, AI and Quantum, Fujitsu Intelligence Technology, Fujitsu
  • Michael Martin, Chief Business Officer, Aurinia Pharma U.S., Inc.
  • Gordon McCauley, President & CEO, adMare BioInnovations
  • Jeremy Mickolwin, Director of Clinic Transformation, WELL Health Technologies
  • Dr. Allan Miranda, Regional Head, JLABS Canada, Johnson & Johnson Innovation, Janssen
  • Dr. Deborah Money, Professor, Obstetrics & Gynaecology, Medicine, & SPPH, University of British Columbia & Clinician Scientist, Women's Health Research Institute
  • Dr. David Parkinson, President & CEO, ESSA Pharma
  • Dr. Simon Pimstone, Co-Founder & CEO, Xenon Pharmaceuticals
  • Dr. Trevor Pugh, Canada Research Chair, Translational Genomics, Senior Scientist, Princess Margaret Cancer Centre, Director, Genomics, Ontario Institute for Cancer Research & Associate Professor, Department of Medical Biophysics, University of Toronto
  • Tracy Redies, President & CEO, Science World
  • Dr. Dean Regier, Assistant Professor, UBC & Scientist, Cancer Control Research, BC Cancer
  • Dr. Amy Salmon, Program Head - Knowledge Translation, CHÉOS
  • Dr. James Taylor, Co-founder & CEO, Precision NanoSystems
  • Dr. Ali Tehrani, President and CEO, Zymeworks
  • Kristin Westland, Director, Operations, CHÉOS
  • Dr. Stephanie Willerth, Professor and Canada Research Chair, Biomedical Engineering, University of Victoria & CEO, Axolotl Biosciences
  • Kory Wilson, Executive Director, Indigenous Initiatives and Partnerships, BCIT
  • Dr. Stephen Yip, Director, Cancer Genetics Lab & Director, Clinical Services, Genome Sciences Center, BC Cancer
  • Dr. Peter Zandstra, Director, School of BME & Michael Smith Labs, University of British Columbia

Event Details

Date: February 24-25, 2021

Time: 8:30AM - 5:00PM PST


$25 for Students

$49 for LSBC Members

$99 for LSBC Non-Members

Register Now

Stay In Touch

Subscribe to our Newsletter for the latest updates